Viking Global Investors

Founded in 1999, Viking Global Investors ("Viking") is a global firm with a fundamental, research-intensive, long-term-focused approach to investing. We currently manage over $49 billion in capital.

 

Viking’s private healthcare team:

  • Dedicated healthcare team with extensive scientific training and deep domain expertise in biotech, medtech, healthcare services and digital health
  • Close collaboration with Viking’s public market team, providing more than 20 years of public investment expertise and insight 
  • Focused on aligning with high-quality companies and best-in-class management teams and providing financial and advisory support to help maximize long-term value as businesses scale

 

Track record highlights:

  • $3.5B+ total capital invested in healthcare since inception
  • 70+ healthcare investments since inception
  • 100% Rate of IPO participation in our healthcare companies
  • $20-$500M+ target deployment per investment


Address

New York
New York
United States

Website

https://vikingglobal.com/

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS

Loading

Countdown